INSIGHTS ON CLINICAL TRIAL PARTNERING

• An Introduction To One Home for Sites™

  This on-demand webinar provides a thorough overview of why IQVIA Technologies is building One Home for Sites, how it works, and who should participate.

• DCTs And Community-Based Research Execution And Compliance

  The FDA's regulatory endorsement of DCTs enhances their credibility, offering a pathway to more inclusive and accessible clinical research that benefits both patients and sponsors.

• Setting A New Client Standard In Study Closeout Timelines

  Learn how a top-10 global pharmaceutical company achieved a significantly faster time to market for a high-profile therapy.

• Harnessing The Potential Of Patient-Level Data In Clinical Trials  

  Join our panel of industry leaders as they explore innovative methods and best practices for incorporating fully consented patient data in clinical trials.

• Global Trials Can't Afford To Overlook Africa

  9/3/2025

  Africa’s trial capacity is growing, but patient services remain the key to retention and reliable outcomes. Sponsors that act now can shape Africa into a true global trial hub.

• What Sponsors Must Know To Safeguard Ocular Endpoints

  7/7/2025

  Explore the necessity of incorporating imaging methodologies early in the trial design to improve data quality and overall trial efficiency.

• On-Demand Service Models Improve Clinical Trials

  12/8/2025

  As consumers increasingly expect convenience and immediacy, the on-demand model continues to reshape how services are delivered across nearly every sector.

• Navigating The Complexities Of Clinical Trial Site Payments Forecasting

  7/9/2024

  Advanced technology and best practices have the potential to revolutionize clinical trial site payment forecasting, leading to significant improvements in overall trial efficiency and management.

• The Real Power Of Digital Payments In Clinical Trials

  10/8/2025

  Digital payments streamline clinical trials by reducing site burden, improving patient experience, eliminating manual delays, and delivering cleaner data across global studies.